Hyperfine (HYPR) Change in Receivables (2021 - 2026)
Hyperfine posted quarterly Change in Receivables of -$1.5 million for Q1 2026, down 133.71% year-on-year from $4.3 million in Q1 2025, and down 497.55% on a QoQ basis from $368000.0 in Q4 2025.
Hyperfine (HYPR) has 6 years of Change in Receivables data on file, last reported at -$1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 133.71% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (down 11738.46% YoY), and the FY2025 full-year result was -$702000.0, down 125.37% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1.5 million, down from $368000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $2.2 million in Q1 2024 and bottomed at -$1.9 million in Q3 2023.
- The 5-year median for Change in Receivables is -$13000.0 (2022), against an average of $190470.6.
- The widest annual swing landed in 2022, when Change in Receivables tumbled 60000.0%; it then soared 4587.5% in 2024.
- A 5-year view of Change in Receivables shows it stood at -$599000.0 in 2022, then jumped by 289.32% to $1.1 million in 2023, then tumbled by 174.43% to -$844000.0 in 2024, then jumped by 143.6% to $368000.0 in 2025, then tumbled by 497.55% to -$1.5 million in 2026.
- The last three Change in Receivables figures came in at -$1.5 million (Q1 2026), $368000.0 (Q4 2025), and -$171000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | 368,000.00 |
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | -171,000.00 |
| Sep 30, 2025 | -171,000.00 |
| Jun 30, 2025 | -273,000.00 |
| Jun 30, 2025 | -273,000.00 |
| Mar 31, 2025 | -626,000.00 |
| Mar 31, 2025 | -626,000.00 |
| Dec 31, 2024 | -844,000.00 |
| Dec 31, 2024 | -844,000.00 |
| Sep 30, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | -1.89 Mn |
| Sep 30, 2023 | -1.89 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Mar 31, 2023 | -48,000.00 |
| Mar 31, 2023 | -48,000.00 |
| Dec 31, 2022 | -599,000.00 |
| Dec 31, 2022 | -599,000.00 |
| Sep 30, 2022 | 715,000.00 |
| Sep 30, 2022 | 715,000.00 |
| Jun 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | -13,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | -1.72 Mn |
| Sep 30, 2021 | -1.72 Mn |
| Jun 30, 2021 | -204,000.00 |
| Jun 30, 2021 | -204,000.00 |
| Mar 31, 2021 | 467,000.00 |
| Mar 31, 2021 | 467,000.00 |